New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence

A multicenter cohort study

Thomas Klikovits, Zoltán Lohinai, Katalin Fábián, Márton Gyulai, Mária Szilasi, Judit Varga, Erika Baranya, Orsolya Pipek, I. Csabai, Zoltán Szállási, J. Tímár, Mir Alireza Hoda, Viktoria Laszlo, Balázs Hegedűs, Ferenc Renyi-Vamos, Walter Klepetko, G. Ostoros, B. Döme, Judit Moldvay

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: The presence of organ metastases is a major factor for unfavorable prognosis in lung adenocarcinoma (LADC). However, the influence of primary tumor location on metastatic sites and sequence has not been extensively analyzed. Methods: We performed a multicenter cohort study, evaluating clinicopathological data of 1126 Caucasian LADC patients, focusing on the distinct location of primary tumors and metastatic sites during disease progression. Results: Metastases to the lung (p < 0.001), pleura (p < 0.001) and adrenal glands (p < 0.001) occurred earlier during disease progression and central primary tumors were associated with early metastases (OR 1.43, p = 0.02). In secondary exploratory analysis we found that bone metastases were more frequent in patients with central tumors (OR 1.86, p = 0.017), whereas lung metastases in those with peripheral tumors (OR 1.35, p = 0.015). Central primary LADCs were associated with decreased median overall survival (vs. peripheral tumors, 10.2 vs. 22 months) both in univariate (HR 2.075, p = 0.001) and in multivariate (HR 1.558, p < 0.001) analyses and independent from stage and T factor. By subsequent analysis, we found that bone metastases tend to appear together with adrenal and liver metastases, and adrenal with skin, and pleural with pericardial metastases more frequently than expected if metastatic events occurred independently. Conclusion: This comprehensive large cohort analysis demonstrates metastatic site- and sequence-specific variations in patients with LADC. Central LADC is associated with early metastatic disease, bone involvement and, consequently, decreased survival.

Original languageEnglish
Pages (from-to)139-148
Number of pages10
JournalLung Cancer
Volume126
DOIs
Publication statusPublished - Dec 1 2018

Fingerprint

Multicenter Studies
Cohort Studies
Neoplasm Metastasis
Neoplasms
Disease Progression
Bone and Bones
Lung
Survival
Adenocarcinoma of lung
Pleura
Bone Diseases
Adrenal Glands
Skin
Liver

Keywords

  • Lung adenocarcinoma
  • Metastases
  • Metastatic pattern
  • Metastatic sites
  • Primary tumor location
  • Survival

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence : A multicenter cohort study. / Klikovits, Thomas; Lohinai, Zoltán; Fábián, Katalin; Gyulai, Márton; Szilasi, Mária; Varga, Judit; Baranya, Erika; Pipek, Orsolya; Csabai, I.; Szállási, Zoltán; Tímár, J.; Hoda, Mir Alireza; Laszlo, Viktoria; Hegedűs, Balázs; Renyi-Vamos, Ferenc; Klepetko, Walter; Ostoros, G.; Döme, B.; Moldvay, Judit.

In: Lung Cancer, Vol. 126, 01.12.2018, p. 139-148.

Research output: Contribution to journalArticle

Klikovits, T, Lohinai, Z, Fábián, K, Gyulai, M, Szilasi, M, Varga, J, Baranya, E, Pipek, O, Csabai, I, Szállási, Z, Tímár, J, Hoda, MA, Laszlo, V, Hegedűs, B, Renyi-Vamos, F, Klepetko, W, Ostoros, G, Döme, B & Moldvay, J 2018, 'New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort study', Lung Cancer, vol. 126, pp. 139-148. https://doi.org/10.1016/j.lungcan.2018.11.004
Klikovits, Thomas ; Lohinai, Zoltán ; Fábián, Katalin ; Gyulai, Márton ; Szilasi, Mária ; Varga, Judit ; Baranya, Erika ; Pipek, Orsolya ; Csabai, I. ; Szállási, Zoltán ; Tímár, J. ; Hoda, Mir Alireza ; Laszlo, Viktoria ; Hegedűs, Balázs ; Renyi-Vamos, Ferenc ; Klepetko, Walter ; Ostoros, G. ; Döme, B. ; Moldvay, Judit. / New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence : A multicenter cohort study. In: Lung Cancer. 2018 ; Vol. 126. pp. 139-148.
@article{d3182f31a3544306a05d297896cfb91f,
title = "New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort study",
abstract = "Introduction: The presence of organ metastases is a major factor for unfavorable prognosis in lung adenocarcinoma (LADC). However, the influence of primary tumor location on metastatic sites and sequence has not been extensively analyzed. Methods: We performed a multicenter cohort study, evaluating clinicopathological data of 1126 Caucasian LADC patients, focusing on the distinct location of primary tumors and metastatic sites during disease progression. Results: Metastases to the lung (p < 0.001), pleura (p < 0.001) and adrenal glands (p < 0.001) occurred earlier during disease progression and central primary tumors were associated with early metastases (OR 1.43, p = 0.02). In secondary exploratory analysis we found that bone metastases were more frequent in patients with central tumors (OR 1.86, p = 0.017), whereas lung metastases in those with peripheral tumors (OR 1.35, p = 0.015). Central primary LADCs were associated with decreased median overall survival (vs. peripheral tumors, 10.2 vs. 22 months) both in univariate (HR 2.075, p = 0.001) and in multivariate (HR 1.558, p < 0.001) analyses and independent from stage and T factor. By subsequent analysis, we found that bone metastases tend to appear together with adrenal and liver metastases, and adrenal with skin, and pleural with pericardial metastases more frequently than expected if metastatic events occurred independently. Conclusion: This comprehensive large cohort analysis demonstrates metastatic site- and sequence-specific variations in patients with LADC. Central LADC is associated with early metastatic disease, bone involvement and, consequently, decreased survival.",
keywords = "Lung adenocarcinoma, Metastases, Metastatic pattern, Metastatic sites, Primary tumor location, Survival",
author = "Thomas Klikovits and Zolt{\'a}n Lohinai and Katalin F{\'a}bi{\'a}n and M{\'a}rton Gyulai and M{\'a}ria Szilasi and Judit Varga and Erika Baranya and Orsolya Pipek and I. Csabai and Zolt{\'a}n Sz{\'a}ll{\'a}si and J. T{\'i}m{\'a}r and Hoda, {Mir Alireza} and Viktoria Laszlo and Bal{\'a}zs Hegedűs and Ferenc Renyi-Vamos and Walter Klepetko and G. Ostoros and B. D{\"o}me and Judit Moldvay",
year = "2018",
month = "12",
day = "1",
doi = "10.1016/j.lungcan.2018.11.004",
language = "English",
volume = "126",
pages = "139--148",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence

T2 - A multicenter cohort study

AU - Klikovits, Thomas

AU - Lohinai, Zoltán

AU - Fábián, Katalin

AU - Gyulai, Márton

AU - Szilasi, Mária

AU - Varga, Judit

AU - Baranya, Erika

AU - Pipek, Orsolya

AU - Csabai, I.

AU - Szállási, Zoltán

AU - Tímár, J.

AU - Hoda, Mir Alireza

AU - Laszlo, Viktoria

AU - Hegedűs, Balázs

AU - Renyi-Vamos, Ferenc

AU - Klepetko, Walter

AU - Ostoros, G.

AU - Döme, B.

AU - Moldvay, Judit

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Introduction: The presence of organ metastases is a major factor for unfavorable prognosis in lung adenocarcinoma (LADC). However, the influence of primary tumor location on metastatic sites and sequence has not been extensively analyzed. Methods: We performed a multicenter cohort study, evaluating clinicopathological data of 1126 Caucasian LADC patients, focusing on the distinct location of primary tumors and metastatic sites during disease progression. Results: Metastases to the lung (p < 0.001), pleura (p < 0.001) and adrenal glands (p < 0.001) occurred earlier during disease progression and central primary tumors were associated with early metastases (OR 1.43, p = 0.02). In secondary exploratory analysis we found that bone metastases were more frequent in patients with central tumors (OR 1.86, p = 0.017), whereas lung metastases in those with peripheral tumors (OR 1.35, p = 0.015). Central primary LADCs were associated with decreased median overall survival (vs. peripheral tumors, 10.2 vs. 22 months) both in univariate (HR 2.075, p = 0.001) and in multivariate (HR 1.558, p < 0.001) analyses and independent from stage and T factor. By subsequent analysis, we found that bone metastases tend to appear together with adrenal and liver metastases, and adrenal with skin, and pleural with pericardial metastases more frequently than expected if metastatic events occurred independently. Conclusion: This comprehensive large cohort analysis demonstrates metastatic site- and sequence-specific variations in patients with LADC. Central LADC is associated with early metastatic disease, bone involvement and, consequently, decreased survival.

AB - Introduction: The presence of organ metastases is a major factor for unfavorable prognosis in lung adenocarcinoma (LADC). However, the influence of primary tumor location on metastatic sites and sequence has not been extensively analyzed. Methods: We performed a multicenter cohort study, evaluating clinicopathological data of 1126 Caucasian LADC patients, focusing on the distinct location of primary tumors and metastatic sites during disease progression. Results: Metastases to the lung (p < 0.001), pleura (p < 0.001) and adrenal glands (p < 0.001) occurred earlier during disease progression and central primary tumors were associated with early metastases (OR 1.43, p = 0.02). In secondary exploratory analysis we found that bone metastases were more frequent in patients with central tumors (OR 1.86, p = 0.017), whereas lung metastases in those with peripheral tumors (OR 1.35, p = 0.015). Central primary LADCs were associated with decreased median overall survival (vs. peripheral tumors, 10.2 vs. 22 months) both in univariate (HR 2.075, p = 0.001) and in multivariate (HR 1.558, p < 0.001) analyses and independent from stage and T factor. By subsequent analysis, we found that bone metastases tend to appear together with adrenal and liver metastases, and adrenal with skin, and pleural with pericardial metastases more frequently than expected if metastatic events occurred independently. Conclusion: This comprehensive large cohort analysis demonstrates metastatic site- and sequence-specific variations in patients with LADC. Central LADC is associated with early metastatic disease, bone involvement and, consequently, decreased survival.

KW - Lung adenocarcinoma

KW - Metastases

KW - Metastatic pattern

KW - Metastatic sites

KW - Primary tumor location

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=85056529395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056529395&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2018.11.004

DO - 10.1016/j.lungcan.2018.11.004

M3 - Article

VL - 126

SP - 139

EP - 148

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

ER -